EUVIMEDEUVIMED entdecken
LeserbriefKommentarRandomisierte kontrollierte Studie

Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trial

Sheng-Yin Chen iD, Vin-Cent Wu iD

European Journal of Endocrinology · 2023

DOI: 10.1093/ejendo/lvad021 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Sheng-Yin Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hyperaldosteronism, Hypertension. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Ministry of Science and Technology, MOST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We thank Dr. Ragnarsson and colleagues1 for their thoughtful comments regarding our recent article.2 They raised some concerns and proposed some opinions that warrant to be discussed. Frist, they mentioned that in most studies of primary aldosteronism (PA), a proportion of patients received inadequate doses of mineralocorticoid receptor antagonist (MRA) and had low renin levels. It was demonstrated from retrospective studies that excess risk of cardiovascular events and mortality was only observed to be associated with patients whose plasma renin levels remained suppressed (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismHypertensionHumansAdrenal GlandsAdrenalectomyAldosteroneRandomized Controlled Trials as Topic

Substanzen

Aldosterone

Autor:innen und Institutionen

  • Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • School of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

ORCID-Profile: Sheng-Yin Chen, Vin-Cent Wu

Förderung

  • Ministry of Science and Technology
  • MOST

Zitieren

APA

Chen, S. Y., & Wu, V. C. (2023). Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trial. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad021

Vancouver

Chen SY, Wu VC. Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trial. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvad021

BibTeX
@article{Chen2023,
  author = {Chen, Sheng-Yin and Wu, Vin-Cent},
  title = {Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trial},
  journal = {European Journal of Endocrinology},
  year = {2023},
  doi = {10.1093/ejendo/lvad021}
}
Kostenlos starten →